Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
WUXI BIO's Major Shareholder Biologics Sells Shrs at 3.7% Discount w/ $5.7B+ Cash, No Longer Major Shareholder
Recommend 7 Positive 12 Negative 8 |
||||
|
||||
|
WUXI BIO (02269.HK) announced that its major shareholder, Biologics Holdings, had entered into a Block Trade Agreement with Morgan Stanley (Placing Agent), pursuant to which the Placing Agent had agreed to place 150 million existing shares of the Company (representing approximately 3.63% of the total issued share capital of the Company) held by Biologics Holdings at a price of HKD38.52 each, which represents a 3.75% discount to WuXi Biologics' closing price of HKD40.02 on the previous day (15th), involving approximately HKD5.778 billion. Ge Li, the chairman of the Board and a non-executive Director, controls approximately 19.66% of the issued share capital of Biologics Holdings and 55.03% of the voting power at the general meetings of Biologics Holdings. Assuming the Placing will be completed as contemplated, the shareholding held by Biologics Holdings in the Company will decrease from approximately 12.12% to 8.49% of the total issued share capital of the Company; and Biologics Holdings will cease to be a substantial shareholder of the Company. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
